Nipah outbreaks in Bangladesh: age and breathing difficulties of infected patients increase the risk of disease spread

Press release
|

Nipah virus, a bat-borne paramyxovirus found throughout South and South East Asia, has been identified by WHO as an emerging infectious disease that may cause severe epidemics in the near future. Infections in humans result in severe respiratory and neurological disease with a high case fatality. With no available treatment or vaccine, the control of Nipah virus outbreaks must rely on a detailed understanding of factors that may facilitate inter-human transmission. In this context, researchers from the Institut Pasteur, CNRS, and Johns Hopkins Bloomberg School of Public Health, worked with colleagues at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the Institute of Epidemiology Disease Control And Research (IEDCR), and the US Centers for Disease Control and Prevention (US CDC), studied the transmission dynamics of Nipah virus during the last 14 years of outbreak investigations in Bangladesh, the country that has reported the largest number of cases. The study showed in particular that adult cases with respiratory symptoms transmitted the virus to more individuals than other cases, and might therefore be targeted for interventions when the isolation of all suspected Nipah cases is not possible. This research paves the way to more efficient control measures. These results will be published in the scientific journal NEJM on May 9, 2019.


Nipah virus is a bat-borne paramyxovirus found throughout South and South East Asia. With a case fatality of >70% and no available treatment or vaccines, Nipah virus was identified by the World Health Organization as an emerging infectious disease that may cause major epidemics if the pathogen evolves to become more transmissible, leading the organization to prioritize it for research to prevent future health emergencies.

In the absence of efficient treatments or vaccines, the only way to control Nipah virus outbreaks are through targeted interventions that limit opportunities of spread. However, designing such interventions is challenging in a context where transmission mechanisms remain poorly understood. Further insights on mechanisms of person-to-person transmission of Nipah virus are therefore urgently needed.

To unravel the drivers of person-to-person transmission of Nipah virus, researchers from the Institut Pasteur, CNRS, icddr,b, IEDCR, US CDC and Johns Hopkins Bloomberg School of Public Health studied the characteristics of all Nipah cases and over 2000 of their contacts identified during the last 14 years of outbreak investigations in Bangladesh, the country that has reported the largest number of cases.

The study showed that, in particular, adult cases with respiratory symptoms transmitted the virus to more individuals than other cases, and therefore might be targeted for interventions when the isolation of all suspected Nipah cases is not possible. Moreover, contacts exposed to body fluids, including respiratory secretions, were more likely to get infected than others- consistent with an important role of respiratory secretions in person-to-person transmission of Nipah virus. The study further showed that spouses of cases and contacts with long exposure duration (often the caregivers) were more likely to get infected and should therefore be the focus of protective measures.

« Epidemic preparedness and the ability to stop transmission efficiently during an outbreak can only be achieved through a detailed understanding of the drivers of Nipah transmission. The detailed outbreak investigations carried out over the last decade by our colleagues from the icddr,b and IEDCR in Bangladesh have made it possible to answer key questions about the transmission of the virus between humans », states Simon Cauchemez, co-senior author of the study and head of the Mathematical Modelling of Infectious Diseases Unit at the Institut Pasteur.

The risk of transmission of Nipah virus depends on the characteristics of the case, like the age or the type of symptoms. As explained by Birgit Nikolay, first author of the study, « the results of this study help identify patients that should be targeted for interventions such as isolation measures if resources are insufficient to cover all suspected Nipah cases. This may help better control the spread of the virus during large outbreaks. »

Despite these important insights, gaps remain in the understanding of Nipah virus person-to-person transmission. Future research should focus on investigating how the virus propagates in the human body and refine criteria to identify likely Nipah spreaders. Further research is also planned to better understand when and where transmission is occurring in bats to help predict spillovers into human populations.

 


Focus on Nipah

Nipah virus is a paramyxovirus (genus Henipavirus). Fruit bats are the natural reservoir and spillover infections of humans mainly occur through ingestion of palm sap contaminated by the virus. Infections in humans result in severe respiratory and neurological disease with a high case fatality (>70%). Outbreaks have been mainly reported in Bangladesh, but few also occurred in Malaysia and India. Nipah virus has also been found in bats in other countries such as India, Thailand, Cambodia and Malaysia.

 


 

Source

Transmission of Nipah Virus — 14 Years of Investigations in Bangladesh, The New England Journal of Medicine, 9 mai 2019

Birgit Nikolay, Dr.rer.nat., Henrik Salje, Ph.D., M. Jahangir Hossain, M.B., B.S., A.K.M. Dawlat Khan, M.A., Hossain M.S. Sazzad, M.B., B.S., Mahmudur Rahman, Ph.D., Peter Daszak, Ph.D., Ute Ströher, Ph.D., Juliet R.C. Pulliam, Ph.D., A. Marm Kilpatrick, Ph.D., Stuart T. Nichol, Ph.D., John D. Klena, Ph.D., Sharmin Sultana, Ph.D., Sayma Afroj, Ph.D., Stephen P. Luby, M.D., Simon Cauchemez, Ph.D., and Emily S. Gurley, Ph.D.

 

AURÉLIE PERTHUISON
Head of press office
33 (0) 1 45 68 89 28

MYRIAM REBEYROTTE
Press officer
33 (0) 1 45 68 81 01

NATHALIE FEUILLET
Press office assistant
33 (0) 1 45 68 81 09

HÉLOISE RAKOVSKY
Press officer
33 (0)1 86 46 78 67

SEND THE PRESS OFFICE AN EMAIL

Back to top